Estimates Revisions Lexicon Pharmaceuticals, Inc.
Stocks
LXRX
US5288723027
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
00:00:00 25/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 2.320 USD | +0.87% |
|
-0.85% | +101.74% |
| 08-24 | Lexicon Pharma Earns $10 Million Milestone Payment from Novo Nordisk | DJ |
| 08-24 | Lexicon Pharmaceuticals Gets $10 Million Novo Nordisk Milestone Payment for LX9851 | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
- Stock Market
- Stocks
- LXRX Stock
- Consensus Lexicon Pharmaceuticals, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
